Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 14c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q2 EPS of ($0.61), $0.14 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• BofA says convenience store sales trail broader retail channels
• Lyntris said to price IPO in lower half of range
• iShares iBoxx $ High Yield Corporate Bond ETF (HYG) call put ratio 5.7 calls to 1 put with a focus on 50K contracts of September 50 calls